Fenoldopam and renal function after partial nephrectomy in a solitary kidney: a randomized, blinded trial.

@article{OHara2013FenoldopamAR,
  title={Fenoldopam and renal function after partial nephrectomy in a solitary kidney: a randomized, blinded trial.},
  author={Jerome F O'Hara and Ramatia Mahboobi and Steven M Novak and A. S. Morale Bonilla and Edward J. Mascha and A. Fergany and Steven C Campbell and Jihad H. Kaouk and Kristina M Kaple and Inderbir S. Gill and Stephanie A Ziegman and Daniel I Sessler},
  journal={Urology},
  year={2013},
  volume={81 2},
  pages={340-5}
}
OBJECTIVE To test the hypothesis that fenoldopam administration ameliorates ischemic injury, preserving the glomerular filtration rate and serum creatinine postoperatively after partial nephrectomy in patients with a solitary kidney. MATERIALS AND METHODS Fenoldopam is a short-acting dopamine-1 receptor agonist that might provide renal protection during ischemic stress. A total of 90 patients with a solitary functioning kidney who were undergoing partial nephrectomy were randomized to… CONTINUE READING
7 Citations
21 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 21 references

A comparison between fenoldopam and low - dose dopamine in early renal dysfunction of critically ill patients

  • N Brienza, V Malcangi
  • Crit Care Med
  • 2006

Similar Papers

Loading similar papers…